PET Scanners Market - Growth Drivers and Challenges
Growth Drivers
- Rising patient pool with chronic diseases: neurodegenerative and cancer diseases are driving the PET demand. In the U.S., nearly 2,041,910 new cases are registered in 2025, requiring PET scans, based on the NCI report in May 2025. Further in Europe, the aging population affected by Alzheimer’s disease has increased. This rising patient pool has increased the adoption of PET scanners for treatment planning and early diagnosis, mainly in the neurology and oncology sectors. Moreover, the reimbursement in these cases from Medicare and European national health systems has surged the installation of advanced scanners across hospitals and diagnostic centers.
- Hybrid imaging and advancements in technology: Companies are advancing their PET scans with AI-enabled image analysis, and digital PET or CT analysis to improve the diagnostic precision. Companies like Siemens Healthineers’ Biograph Vision Quadra in 2023 have provided scan results faster with 10 times higher effective sensitivity and lower radiation. Companies are nowadays actively investing in AI and hybrid systems to dominate the market. These innovations are improving the patient throughput and expanding the PET application in infectious diseases and cardiology sectors. Manufacturers are making strategic collaborations with AI developers and research institutions to drive precision medicine initiatives and personalized diagnostics.
- Strong government spending and reimbursement guidelines: Government funding for Medicare and Medicaid is propelling the PET scanner adoption. Medicare expenditure in 2023 on PET scans has grown, affecting the increasing demand for diagnostics. FDA has widened the approvals for PET in neurology and oncology increases the reimbursement. The CMS announcement in 2022 to cover amyloid PET scans for Alzheimer's has increased access. In addition, nations such as Germany and Japan have amplified the public expenditure on advanced imaging. Further, to improve the market penetration, the manufacturers are concentrating on harmonizing with the reimbursement policies.
Leading Cancer Sites in 2022
|
Rank |
Males – Leading Cancer Sites |
% Share |
Females – Leading Cancer Sites |
% Share |
|
1 |
Lung |
10.6% |
Breast |
28.8% |
|
2 |
Mouth |
8.4% |
Cervix |
10.6% |
|
3 |
Prostate |
6.1% |
Ovary |
6.2% |
|
4 |
Tongue |
5.9% |
Corpus Uteri |
3.7% |
|
5 |
Stomach |
4.8% |
Lung |
3.7% |
Source: NLM, March 2023
Cancer Death Rate by Type in 2021
|
Type |
Death Rate |
|
Lung, trachea and bronchus |
25.6 |
|
Colon and rectum |
13.2 |
|
Stomach |
12.1 |
|
Breast |
8.5 |
|
Esophageal |
6.8 |
|
Pancreas |
6.4 |
Source: Our World in Data, 2021
Challenges
- Affordability criteria in the developing country: In India, limited hospitals have PET scanners, as they are too expensive. United Imaging introduced a system that captures most of the market share. Limited insurance coverage and high out-of-pocket costs limit patient access to advanced diagnostics. Public-private partnerships are being considered for subsidizing scan prices and expanding infrastructure. As domestic production scales, the affordability is expected to rise, hence unlocking growth opportunities in tier-2 and tier-3 cities.
PET Scanners Market Size and Forecast:
|
Base Year |
2025 |
|
Forecast Year |
2026-2035 |
|
CAGR |
3.9% |
|
Base Year Market Size (2025) |
USD 2.5 billion |
|
Forecast Year Market Size (2035) |
USD 3.6 billion |
|
Regional Scope |
|
Browse key industry insights with market data tables & charts from the report:
Frequently Asked Questions (FAQ)
In 2026, the industry size of PET scanners is assessed at USD 2.6 billion.
PET Scanners Market size was valued at USD 2.5 billion in 2025 and is projected to reach USD 3.6 billion by the end of 2035, rising at a CAGR of 3.9% during the forecast period, i.e., 2026-2035.
North America industry is predicted to account for the largest share of 38.9% by 2035, owing to the rising ageing population and growing chronic disease burden in the region.
The major players in the market are General de Equipment for Medical Imaging, S.A.,Koninklijke Philips N.V., Neusoft Corporation, Siemens Healthcare GmbH, Segami Corporation, Spectrum Dynamics Medical, Inc., Hitachi, Ltd., and others.
